Which of the following is not considered a potential adverse event of TB preventive therapy?

The correct answer pertains to renal toxicity not being a commonly recognized adverse event associated with tuberculosis (TB) preventive therapy. While TB treatment can involve various medications that have specific side effects, renal toxicity is not typically a concern in the context of preventive therapy.

In contrast, hepatitis is a recognized adverse event since some TB preventive therapies, particularly those involving isoniazid, can cause liver function abnormalities. Nausea and vomiting are common side effects as well; many patients experience gastrointestinal disturbances from medications used in TB therapy. Similarly, flu-like syndrome can occur in some individuals taking preventive treatment, leading to symptoms such as fever and malaise.

Understanding the specific risks associated with each medication used in TB preventive therapy is crucial for healthcare providers to monitor and manage patient safety effectively. Recognizing that renal toxicity is not specifically noted among those risks reflects an awareness of relevant side effect profiles.